Axxess 2025 AGILE Conference to Be Held May 5-7 in Dallas
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Agile Therapeutics, Inc. Buyout
Agile Therapeutics AGRX Merger; Lyell Immunopharma LYRL Patient Death
Agile Therapeutics to Be Acquired by Spain-based Insud for an Enterprise Value of ~$45M
Express News | Agile Therapeutics Inc - Insud to Provide Agile With up to $8 Million Line of Credit
Express News | Agile Therapeutics Inc - Insud to Acquire Agile for $1.52 per Share in Cash
Express News | Agile Therapeutics Inc - to Merge With Insud Pharma's US Subsidiary
Express News | Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.l.
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; ISun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. From The Nasdaq...
10-Q: Quarterly report
Express News | Agile Therapeutics Q1 2024 Adj EPS $(0.63) Misses $(0.51) Estimate, Sales $5.72M Beat $3.75M Estimate
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M
Agile Therapeutics 1Q EPS 28c >AGRX
Express News | Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Agile Premium Finance Partners With EPayPolicy to Make Financing at Checkout Easier for Insurance Industry Clients
Agile Therapeutics Releases Updated Investor Presentation
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript
Agile Therapeutics' Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
Q4 2023 Agile Therapeutics Inc Earnings Call
Earnings Call Summary | Agile Therapeutics(AGRX.US) Q4 2023 Earnings Conference
No Data